Clinical Trials Browser

Phase 1/2 × Non Small Cell Lung Cancer Metastatic × Nivolumab × Clear all

NCT03168464 2023-04-24

Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)

Phase 1/2 Terminated

15 enrolled 9 charts

Non Small Cell Lung Cancer Metastatic